RecruitingPhase 3NCT06954441
V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency
Studying Agammaglobulinemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA.
- Principal Investigator
- Israel Silva Maia, PhDHospital do Coracao
- Intervention
- Intravenous immunoglobulin (IVIG)(biological)
- Enrollment
- 50 enrolled
- Eligibility
- 2 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- IMIP Centro de Pesquisa, Recife, Pernanbuco, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06954441 on ClinicalTrials.gov